274 related articles for article (PubMed ID: 11964462)
1. Biomedicine. Back to an aspirin a day?
Vane JR
Science; 2002 Apr; 296(5567):474-5. PubMed ID: 11964462
[No Abstract] [Full Text] [Related]
2. Role of prostacyclin in the cardiovascular response to thromboxane A2.
Cheng Y; Austin SC; Rocca B; Koller BH; Coffman TM; Grosser T; Lawson JA; FitzGerald GA
Science; 2002 Apr; 296(5567):539-41. PubMed ID: 11964481
[TBL] [Abstract][Full Text] [Related]
3. Why do COX-2 inhibitors increase risk of cardiovascular events?
Frankish H
Lancet; 2002 Apr; 359(9315):1410. PubMed ID: 11978344
[No Abstract] [Full Text] [Related]
4. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
Weir MR; Sperling RS; Reicin A; Gertz BJ
Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
[TBL] [Abstract][Full Text] [Related]
5. COX-2 inhibitors: no pain, no heart gain?
Harv Heart Lett; 2001 Dec; 12(4):2-4. PubMed ID: 11751079
[No Abstract] [Full Text] [Related]
6. Coxibs and cardiovascular disease.
Fitzgerald GA
N Engl J Med; 2004 Oct; 351(17):1709-11. PubMed ID: 15470192
[No Abstract] [Full Text] [Related]
7. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
Ray WA; MacDonald TM; Solomon DH; Graham DJ; Avorn J
Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850
[No Abstract] [Full Text] [Related]
8. [New anti-inflammatory analgetics--are they needed?].
Paakkari I
Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925
[No Abstract] [Full Text] [Related]
9. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
[No Abstract] [Full Text] [Related]
10. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
Patrignani P
Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
[No Abstract] [Full Text] [Related]
11. [Specific inhibitors of cyclooxygenase type 2] ].
Tomasová-Studýnková J
Vnitr Lek; 2002 May; 48(5):403-8. PubMed ID: 12061207
[TBL] [Abstract][Full Text] [Related]
12. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
Atkinson HG
Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
[No Abstract] [Full Text] [Related]
13. An update on specific COX-2 inhibitors: the COXIBs.
Gupta S; Crofford LJ
Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091
[No Abstract] [Full Text] [Related]
14. COX-2 inhibitors: new drugs for the management of pain and inflammation.
Hutchins V; Hutchins B
Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
[No Abstract] [Full Text] [Related]
15. Effects of cyclooxygenases inhibitors on vasoactive prostanoids and thrombin generation at the site of microvascular injury in healthy men.
Tuleja E; Mejza F; Cmiel A; Szczeklik A
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1111-5. PubMed ID: 12730088
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.
Patrono C; Patrignani P; García Rodríguez LA
J Clin Invest; 2001 Jul; 108(1):7-13. PubMed ID: 11435450
[No Abstract] [Full Text] [Related]
17. Wolf in sheep's clothing?
Varga J
Am J Hosp Palliat Care; 2000; 17(4):280. PubMed ID: 11883807
[No Abstract] [Full Text] [Related]
18. Cyclooxygenase inhibition in patients with coronary artery disease.
Frishman WH
J Am Coll Cardiol; 2004 Feb; 43(4):532-3. PubMed ID: 14975459
[No Abstract] [Full Text] [Related]
19. Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor.
Schellenberg RR; Isserow SH
N Engl J Med; 2001 Dec; 345(25):1856. PubMed ID: 11752370
[No Abstract] [Full Text] [Related]
20. [No loss of effectiveness with rofecoxib. Long-term control of rheumatoid pain].
Einecke D
MMW Fortschr Med; 2002 Nov; 144(46):68. PubMed ID: 12534087
[No Abstract] [Full Text] [Related]
[Next] [New Search]
